Reports

Global Ethosuximide Market to Grow at a Healthy Pace During 2021-2026, Aided by the Rising Health Consciousness

Ethosuximide Market

Global Ethosuximide Market: By Form: Capsule, Tablet, Syrup; By Application: Hospitals, Drug Stores; Regional Analysis; Historical Market and Forecast (2018-2028); Market Dynamics; Value Chain Analysis; Competitive Landscape; Industry Events and Developments

Global Ethosuximide Market Outlook

The global ethosuximide market is being driven by the growth of the epilepsy drug market, which is expected to grow in the forecast period of 2023-2028 at a CAGR of 4%.

 

Ethosuximide Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America to be a Significant Regional Market for Ethosuximide

The global ethosuximide industry is anticipated to witness a healthy growth over the forecast period. North America is expected to emerge as a significant market for ethosuximide in the coming years. There is a high demand for the drug in this region owing to the rising number of patients suffering from seizures. Apart from North America, Europe is expected to hold a substantial share of the global ethosuximide industry. The increased adoption of the drug for various medications in India and China is contributing towards the market growth in the Asia Pacific region. The Middle East and Africa and Latin America are predicted to witness a steady growth.

 

Ethosuximide Market by Application

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Ethosuximide: Market Segmentation

Ethosuximide is a medication used in the treatment of absence seizures. Absence seizures are characterised by a brief, sudden lapse of consciousness. It is commonly sold under the brand name Zarontin.

The major forms of ethosuximide are:

  • Capsule
  • Tablet
  • Syrup

The market can be broadly categorised based on its applications segments into:

  • Hospitals
  • Drug Stores

The EMR report looks into the regional markets of ethosuximide like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Ethosuximide Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Number of Seizure Patients are Driving the Market Growth of Ethosuximide

The global market for ethosuximide is being driven by the increasing number of patients suffering from absence seizures. Absence seizures are a medical disorder characterised by the temporary, sudden lapse in consciousness. Unlike its alternative valproic acid, which contains idiosyncratic hepatoxicity, ethosuximide is considered to be the primary drug for the treatment of absence seizures. The increasing investments in research and development by the government is aiding the market. Increasing health consciousness and improved living standards are expected to boost the market growth further. These factors are anticipated to bolster the global ethosuximide industry over the forecast period of 2023-2028.

 

Key Industry Players in the Global Ethosuximide Market

The report presents a detailed analysis of the following key players in the global ethosuximide market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Pfizer Inc.
  • Akorn, Incorporated
  • Chemwerth, Inc
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Form, Application, Region
Breakup by Form Capsule, Tablet, Syrup
Breakup by Application Hospitals, Drug Stores
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Pfizer Inc., Akorn, Incorporated, Chemwerth, Inc, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description
    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary
    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Ethosuximide Market Analysis
    8.1    Key Industry Highlights
    8.2    Global Ethosuximide Historical Market (2018-2022) 
    8.3    Global Ethosuximide Market Forecast (2023-2028)
    8.4    Global Ethosuximide Market by Form
        8.4.1    Capsule
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    Tablet
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
        8.4.3    Syrup
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2018-2022)
            8.4.3.3    Forecast Trend (2023-2028)
    8.5    Global Ethosuximide Market by Application
        8.5.1    Hospitals
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Drug Stores
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028) 
    8.6    Global Ethosuximide Market by Region
        8.6.1    North America
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022)
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Europe
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022)
            8.6.2.3    Forecast Trend (2023-2028)
        8.6.3    Asia Pacific
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2018-2022)
            8.6.3.3    Forecast Trend (2023-2028)
        8.6.4    Latin America
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2018-2022)
            8.6.4.3    Forecast Trend (2023-2028)
        8.6.5    Middle East and Africa
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2018-2022)
            8.6.5.3    Forecast Trend (2023-2028)
9    North America Ethosuximide Market Analysis
    9.1    United States of America
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2022)
        9.1.3    Forecast Trend (2023-2028)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2022)
        9.2.3    Forecast Trend (2023-2028)
10    Europe Ethosuximide Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2022)
        10.1.3    Forecast Trend (2023-2028)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2022)
        10.2.3    Forecast Trend (2023-2028)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2018-2022)
        10.3.3    Forecast Trend (2023-2028)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2018-2022)
        10.4.3    Forecast Trend (2023-2028)
    10.5    Others
11    Asia Pacific Ethosuximide Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2022)
        11.1.3    Forecast Trend (2023-2028)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2022)
        11.2.3    Forecast Trend (2023-2028)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2022)
        11.3.3    Forecast Trend (2023-2028)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2022)
        11.4.3    Forecast Trend (2023-2028)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2022)
        11.5.3    Forecast Trend (2023-2028)
    11.6    Others
12    Latin America Ethosuximide Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2022)
        12.1.3    Forecast Trend (2023-2028)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2022)
        12.2.3    Forecast Trend (2023-2028)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2018-2022)
        12.3.3    Forecast Trend (2023-2028)
    12.4    Others
13    Middle East and  Africa Ethosuximide Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2018-2022)
        13.1.3    Forecast Trend (2023-2028)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2018-2022)
        13.2.3    Forecast Trend (2023-2028)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2018-2022)
        13.3.3    Forecast Trend (2023-2028)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2018-2022)
        13.4.3    Forecast Trend (2023-2028)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape
    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    Pfizer Inc.
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    Akorn, Incorporated
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    Chemwerth, Inc
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    Others
17    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Ethosuximide Market: Key Industry Highlights, 2018 and 2028
2.    Global Ethosuximide Historical Market: Breakup by Form (USD Million), 2018-2022
3.    Global Ethosuximide Market Forecast: Breakup by Form (USD Million), 2023-2028
4.    Global Ethosuximide Historical Market: Breakup by Application (USD Million), 2018-2022
5.    Global Ethosuximide Market Forecast: Breakup by Application (USD Million), 2023-2028
6.    Global Ethosuximide Historical Market: Breakup by Region (USD Million), 2018-2022
7.    Global Ethosuximide Market Forecast: Breakup by Region (USD Million), 2023-2028
8.    North America Ethosuximide Historical Market: Breakup by Country (USD Million), 2018-2022
9.    North America Ethosuximide Market Forecast: Breakup by Country (USD Million), 2023-2028
10.    Europe Ethosuximide Historical Market: Breakup by Country (USD Million), 2018-2022
11.    Europe Ethosuximide Market Forecast: Breakup by Country (USD Million), 2023-2028
12.    Asia Pacific Ethosuximide Historical Market: Breakup by Country (USD Million), 2018-2022
13.    Asia Pacific Ethosuximide Market Forecast: Breakup by Country (USD Million), 2023-2028
14.    Latin America Ethosuximide Historical Market: Breakup by Country (USD Million), 2018-2022
15.    Latin America Ethosuximide Market Forecast: Breakup by Country (USD Million), 2023-2028
16.    Middle East and Africa Ethosuximide Historical Market: Breakup by Country (USD Million), 2018-2022
17.    Middle East and Africa Ethosuximide Market Forecast: Breakup by Country (USD Million), 2023-2028
18.    Global Ethosuximide Market Structure

Key Questions Answered in the Report

What is the growth rate of the global ethosuximide market?

The global ethosuximide market is expected to be driven by the global epilepsy drug market, which is projected to grow at a CAGR of 4% between 2023 and 2028.

What are the major market drivers?

The major drivers of the industry, such as rising disposable incomes, growing health consciousness, rapid urbanisation, growing population, and the increasing number of patients affected by absence seizures, are expected to aid the market growth.

What are the key industry trends of the global ethosuximide market?

The key trends guiding the growth of the industry are the rising product awareness and health consciousness among the consumers.

What are the major regional markets of ethosuximide, according to the EMR report?

The major regional markets of ethosuximide are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

What are the different forms of ethosuximide?

The major forms of ethosuximide are tablet, capsule, and syrup.

What are the major applications of the drug?

Ethosuximide finds its application in hospitals and drug stores.

Who are the key industry players, according to the report?

The key industry players include Pfizer Inc., Akorn, Incorporated, and Chemwerth, Inc, among others.

Analyst Review

The global ethosuximide market is being driven by the global epilepsy drug market. Aided by the rising health consciousness, the global epilepsy drug market is expected to witness a further growth in the forecast period of 2023-2028, growing at a CAGR of 4%.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its forms, the market can be segmented into capsules, tablets, and syrups. By application, the market is categorised into hospitals and drug stores. The major regional markets for ethosuximide are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Pfizer Inc., Akorn, Incorporated, and Chemwerth, Inc, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now

Single User License

$2799
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now
most popular

Five User License

$3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now

Corporate License

$4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
Buy Now

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER